Cancer Research AACR Membership Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shureiqi, I.
Right arrow Articles by Lippman, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shureiqi, I.
Right arrow Articles by Lippman, S. M.
[Cancer Research 61, 6307-6312, September 1, 2001]
© 2001 American Association for Cancer Research

Perspectives in Cancer Research

Lipoxygenase Modulation to Reverse Carcinogenesis1

Imad Shureiqi and Scott M. Lippman2

Departments of Clinical Cancer Prevention [I. S., S. M. L.], Gastrointestinal Medical Oncology [I. S.], and Thoracic/Head and Neck Medical Oncology [S. M. L.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

ABSTRACT

New studies of the relationship between polyunsaturated fatty acid metabolismand carcinogenesis have led to novel molecular targets for cancer chemoprevention research. These targets include procarcinogenic lipoxygenases (LOXs), including 5-, 8-, and 12-LOX, and anticarcinogenic LOXs, including 15-LOX-1 and possibly 15-LOX-2. Recent studies indicate that 15-LOX-1 is down-regulated in colorectal cancer cells and that the ability of nonsteroidal anti-inflammatory drugs, a class of clinically active cancer chemopreventive agents, to induce apoptosis and growth inhibition in these cells was dependent on the induction of 15-LOX-1 and its metabolic product 13-S-hydroxyoctadecadienoic acid. Consistent with the colorectal studies, 15-LOX very recently has shown anticarcinogenic activity in esophageal and prostatic carcinogenesis. Inhibitors of other LOXs (e.g., 5-LOX) have preclinical anticarcinogenic activity and are being developed for clinical chemoprevention study. These and other LOX data led us to propose that the various LOX pathways exist in a dynamic balance that shifts during carcinogenesis toward 5-, 8-, and 12-LOX (and cyclooxygenase-2) and away from 15-LOX. A novel approach for cancer chemoprevention would involve LOX modulators, i.e., agents that can induce the anticarcinogenic and/or inhibit the procarcinogenic LOXs, thereby shifting the balance of LOX activities from procarcinogenic to anticarcinogenic metabolism of polyunsaturated fatty acids.




This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. Wang, E. M. John, and S. A. Ingles
5-Lipoxygenase and 5-Lipoxygenase-Activating Protein Gene Polymorphisms, Dietary Linoleic Acid, and Risk for Breast Cancer
Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2748 - 2754.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. F. McEntee, C. Ziegler, D. Reel, K. Tomer, A. Shoieb, M. Ray, X. Li, N. Neilsen, F. B. Lih, D. O'Rourke, et al.
Dietary n-3 Polyunsaturated Fatty Acids Enhance Hormone Ablation Therapy in Androgen-Dependent Prostate Cancer
Am. J. Pathol., July 1, 2008; 173(1): 229 - 241.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
X. Zuo, L. Shen, J.-P. Issa, O. Moy, J. S. Morris, S. M. Lippman, and I. Shureiqi
15-Lipoxygenase-1 transcriptional silencing by DNA methyltransferase-1 independently of DNA methylation
FASEB J, June 1, 2008; 22(6): 1981 - 1992.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Y.-S. Piao, Y.-C. Du, H. Oshima, J.-C. Jin, M. Nomura, T. Yoshimoto, and M. Oshima
Platelet-type 12-lipoxygenase accelerates tumor promotion of mouse epidermal cells through enhancement of cloning efficiency
Carcinogenesis, February 1, 2008; 29(2): 440 - 447.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
H. Viita, J. Markkanen, E. Eriksson, M. Nurminen, K. Kinnunen, M. Babu, T. Heikura, S. Turpeinen, S. Laidinen, T. Takalo, et al.
15-Lipoxygenase-1 Prevents Vascular Endothelial Growth Factor A- and Placental Growth Factor-Induced Angiogenic Effects in Rabbit Skeletal Muscles via Reduction in Growth Factor mRNA Levels, NO Bioactivity, and Downregulation of VEGF Receptor 2 Expression
Circ. Res., February 1, 2008; 102(2): 177 - 184.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
W. Tan, J. Wu, X. Zhang, Y. Guo, J. Liu, T. Sun, B. Zhang, D. Zhao, M. Yang, D. Yu, et al.
Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer
Carcinogenesis, June 1, 2007; 28(6): 1197 - 1201.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
E. M. Poole, J. Bigler, J. Whitton, J. G. Sibert, R. J. Kulmacz, J. D. Potter, and C. M. Ulrich
Genetic variability in prostaglandin synthesis, fish intake and risk of colorectal polyps
Carcinogenesis, June 1, 2007; 28(6): 1259 - 1263.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
F. Cianchi, C. Cortesini, L. Magnelli, E. Fanti, L. Papucci, N. Schiavone, L. Messerini, A. Vannacci, S. Capaccioli, F. Perna, et al.
Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells.
Mol. Cancer Ther., November 1, 2006; 5(11): 2716 - 2726.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Z. Sun, S. Sood, N. Li, D. Ramji, P. Yang, R. A. Newman, C. S. Yang, and X. Chen
Involvement of the 5-lipoxygenase/leukotriene A4 hydrolase pathway in 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch, and inhibition of carcinogenesis by its inhibitors
Carcinogenesis, September 1, 2006; 27(9): 1902 - 1908.
[Abstract] [Full Text] [PDF]

Home page
 J BiochemHome page
L. Du, Z. Zhang, X. Luo, K. Chen, X. Shen, and H. Jiang
Binding Investigation of Human 5-Lipoxygenase with Its Inhibitors by SPR Technology Correlating with Molecular Docking Simulation.
J. Biochem., April 1, 2006; 139(4): 715 - 723.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. M. Lippman and J. J. Lee
Reducing the "Risk" of Chemoprevention: Defining and Targeting High Risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture.
Cancer Res., March 15, 2006; 66(6): 2893 - 2903.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
E. M. Poole, J. Bigler, J. Whitton, J. G. Sibert, J. D. Potter, and C. M. Ulrich
Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps.
Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 502 - 508.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I. Shureiqi, Y. Wu, D. Chen, X. L. Yang, B. Guan, J. S. Morris, P. Yang, R. A. Newman, R. Broaddus, S. R. Hamilton, et al.
The Critical Role of 15-Lipoxygenase-1 in Colorectal Epithelial Cell Terminal Differentiation and Tumorigenesis
Cancer Res., December 15, 2005; 65(24): 11486 - 11492.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Deguchi, S. W. Xing, I. Shureiqi, P. Yang, R. A. Newman, S. M. Lippman, S. J. Feinmark, B. Oehlen, and I. B. Weinstein
Activation of Protein Kinase G Up-regulates Expression of 15-Lipoxygenase-1 in Human Colon Cancer Cells
Cancer Res., September 15, 2005; 65(18): 8442 - 8447.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. A. Nony, S. B. Kennett, W. C. Glasgow, K. Olden, and J. D. Roberts
15(S)-Lipoxygenase-2 Mediates Arachidonic Acid-stimulated Adhesion of Human Breast Carcinoma Cells through the Activation of TAK1, MKK6, and p38 MAPK
J. Biol. Chem., September 9, 2005; 280(36): 31413 - 31419.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
B. Rigas and K. Kashfi
Cancer Prevention: A New Era beyond Cyclooxygenase-2
J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 1 - 8.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
L A A Brosens, J J Keller, G J A Offerhaus, M Goggins, and F M Giardiello
Prevention and management of duodenal polyps in familial adenomatous polyposis
Gut, July 1, 2005; 54(7): 1034 - 1043.
[Full Text] [PDF]

Home page
 JCOHome page
F. R. Hirsch and S. M. Lippman
Advances in the Biology of Lung Cancer Chemoprevention
J. Clin. Oncol., May 10, 2005; 23(14): 3186 - 3197.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Y.N. Ye, W.K.K. Wu, V.Y. Shin, I.C. Bruce, B.C.Y. Wong, and C.H. Cho
Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke
Carcinogenesis, April 1, 2005; 26(4): 827 - 834.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
A. Hoque, S. M. Lippman, T.-T. Wu, Y. Xu, Z. D. Liang, S. Swisher, H. Zhang, L. Cao, J. A. Ajani, and X.-c. Xu
Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention
Carcinogenesis, April 1, 2005; 26(4): 785 - 791.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. E. Goodman, E. D. Bowman, S. J. Chanock, A. J. Alberg, and C. C. Harris
Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk
Carcinogenesis, December 1, 2004; 25(12): 2467 - 2472.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
A. J. Duffield-Lillico, I. Shureiqi, and S. M. Lippman
Can Selenium Prevent Colorectal Cancer? A Signpost From Epidemiology
J Natl Cancer Inst, November 17, 2004; 96(22): 1645 - 1647.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. Coffa and A. R. Brash
A single active site residue directs oxygenation stereospecificity in lipoxygenases: Stereocontrol is linked to the position of oxygenation
PNAS, November 2, 2004; 101(44): 15579 - 15584.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Y. N. Ye, E. S. L. Liu, V. Y. Shin, W. K. K. Wu, and C. H. Cho
The Modulating Role of Nuclear Factor-{kappa}B in the Action of {alpha}7-Nicotinic Acetylcholine Receptor and Cross-Talk between 5-Lipoxygenase and Cyclooxygenase-2 in Colon Cancer Growth Induced by 4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 123 - 130.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
P. J. Moos, K. Edes, J. E. Mullally, and F. A. Fitzpatrick
Curcumin impairs tumor suppressor p53 function in colon cancer cells
Carcinogenesis, September 1, 2004; 25(9): 1611 - 1617.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. K. Yu, P. J. Moos, P. Cassidy, M. Wade, and F. A. Fitzpatrick
Conditional Expression of 15-Lipoxygenase-1 Inhibits the Selenoenzyme Thioredoxin Reductase: MODULATION OF SELENOPROTEINS BY LIPOXYGENASE ENZYMES
J. Biol. Chem., July 2, 2004; 279(27): 28028 - 28035.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
E. S. Schernhammer, J.-H. Kang, A. T. Chan, D. S. Michaud, H. G. Skinner, E. Giovannucci, G. A. Colditz, and C. S. Fuchs
A Prospective Study of Aspirin Use and the Risk of Pancreatic Cancer in Women
J Natl Cancer Inst, January 7, 2004; 96(1): 22 - 28.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
N Nathoo, G H Barnett, and M Golubic
The eicosanoid cascade: possible role in gliomas and meningiomas
J. Clin. Pathol., January 1, 2004; 57(1): 6 - 13.
[Abstract] [Full Text] [PDF]

Home page
 Indoor and Built EnvironmentHome page
W. E. Criss
Molecular Mechanisms of Toxic Chemicals
Indoor and Built Environment, December 1, 2003; 12(6): 395 - 399.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
A. L. Sabichi, M.-F. Demierre, E. T. Hawk, C. E. Lerman, and S. M. Lippman
Frontiers in Cancer Prevention Research
Cancer Res., September 15, 2003; 63(18): 5649 - 5655.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Weggen, J. L. Eriksen, S. A. Sagi, C. U. Pietrzik, V. Ozols, A. Fauq, Todd. E. Golde, and E. H. Koo
Evidence That Nonsteroidal Anti-inflammatory Drugs Decrease Amyloid {beta}42 Production by Direct Modulation of {gamma}-Secretase Activity
J. Biol. Chem., August 22, 2003; 278(34): 31831 - 31837.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. B. Shappell, S. J. Olson, S. E. Hannah, S. Manning, R. L. Roberts, N. Masumori, M. Jisaka, W. E. Boeglin, V. Vader, D. S. Dave, et al.
Elevated Expression of 12/15-Lipoxygenase and Cyclooxygenase-2 in a Transgenic Mouse Model of Prostate Carcinoma
Cancer Res., May 1, 2003; 63(9): 2256 - 2267.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. A. Baron, B. F. Cole, R. S. Sandler, R. W. Haile, D. Ahnen, R. Bresalier, G. McKeown-Eyssen, R. W. Summers, R. Rothstein, C. A. Burke, et al.
A Randomized Trial of Aspirin to Prevent Colorectal Adenomas
N. Engl. J. Med., March 6, 2003; 348(10): 891 - 899.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. Wu, H. H. X. Xia, S. P. Tu, D. M. Fan, M. C. M. Lin, H. F. Kung, S. K. Lam, and B. C. Y. Wong
15-Lipoxygenase-1 mediates cyclooxygenase-2 inhibitor-induced apoptosis in gastric cancer
Carcinogenesis, February 1, 2003; 24(2): 243 - 247.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
X. Chen, N. Li, S. Wang, J. Hong, M. Fang, J. Yousselfson, P. Yang, R. A. Newman, R. A. Lubet, and C. S. Yang
Aberrant arachidonic acid metabolism in esophageal adenocarcinogenesis, and the effects of sulindac, nordihydroguaiaretic acid, and {alpha}-difluoromethylornithine on tumorigenesis in a rat surgical model
Carcinogenesis, December 1, 2002; 23(12): 2095 - 2102.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. M. Lippman and W. K. Hong
Cancer Prevention Science and Practice
Cancer Res., September 15, 2002; 62(18): 5119 - 5125.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
P. E. Lovat, S. Oliverio, M. Ranalli, M. Corazzari, C. Rodolfo, F. Bernassola, K. Aughton, M. Maccarrone, Q. D. C. Hewson, A. D. J. Pearson, et al.
GADD153 and 12-Lipoxygenase Mediate Fenretinide-induced Apoptosis of Neuroblastoma
Cancer Res., September 15, 2002; 62(18): 5158 - 5167.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. Greenwald
Cancer Prevention Clinical Trials
J. Clin. Oncol., September 15, 2002; 20(90001): 14s - 22.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Muller, M. Siebert, M. Heidt, F. Marks, P. Krieg, and G. Furstenberger
Modulation of Epidermal Tumor Development Caused by Targeted Overexpression of Epidermis-type 12S-Lipoxygenase
Cancer Res., August 15, 2002; 62(16): 4610 - 4616.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
K. E. Anderson, T. W. Johnson, D. Lazovich, and A. R. Folsom
Association Between Nonsteroidal Anti-Inflammatory Drug Use and the Incidence of Pancreatic Cancer
J Natl Cancer Inst, August 7, 2002; 94(15): 1168 - 1171.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. S. Carlton, R. Gopalakrishnan, A. Gupta, B. W. Liston, S. Habib, M. A. Morse, and G. D. Stoner
Piroxicam Is an Ineffective Inhibitor of N-Nitrosomethylbenzylamine-induced Tumorigenesis in the Rat Esophagus
Cancer Res., August 1, 2002; 62(15): 4376 - 4382.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. M. Lippman and W. Ki Hong
Cancer Prevention by Delay : Commentary re: J. A. O'Shaughnessy et al., Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development. Clin. Cancer Res., 8: 314-346, 2002.
Clin. Cancer Res., February 1, 2002; 8(2): 305 - 313.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.